Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 704 (USA) (Dr. Tanaka)
· consented 2013-01-13
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-30 (study day 18.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-25 (study day 44.0); relationship: NONE
severe
assessed
2026-08-18
Severe TRANSIENT ISCHAEMIC ATTACK — outcome: RECOVERED/RESOLVED; onset 2013-02-21 (study day 40.0); relationship: NONE; serious criteria: hospitalization
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.